Variant report

Variant	nsv548609
Chromosome Location	chr1:191788524-191804265
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr1:191788611..191790988-chr1:191796591..191799173,2	MCF-7	breast:
2	chr1:191788611..191790988-chr1:191796591..191799173,2	MCF-7	breast:
3	chr1:191802155..191804937-chr1:191853608..191855643,2	K562	blood:
4	chr1:191784628..191787361-chr1:191791989..191794077,2	K562	blood:
5	chr1:190926824..190927388-chr1:191800448..191800967,2	MCF-7	breast:

Extended variants
information (count: 91 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:91 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs200320371	chr1:191791613-191791614	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs563519189	chr1:191791634-191791635	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs377029063	chr1:191791636-191791637	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs569405983	chr1:191791668-191791669	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs538070727	chr1:191791747-191791748	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs554632310	chr1:191791794-191791795	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs568089452	chr1:191791804-191791805	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs570703262	chr1:191791831-191791832	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs183591102	chr1:191791886-191791887	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs553844470	chr1:191791921-191791922	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs548635660	chr1:191791958-191791959	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs546074237	chr1:191792036-191792037	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs142352138	chr1:191792038-191792039	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs576155361	chr1:191792078-191792079	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs144374390	chr1:191792139-191792140	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs561414127	chr1:191792142-191792143	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs530171291	chr1:191792148-191792149	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs189772683	chr1:191792165-191792166	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs79332112	chr1:191792193-191792194	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs7528316	chr1:191792216-191792217	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs368840678	chr1:191792258-191792259	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs552419047	chr1:191792261-191792262	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs549664463	chr1:191792327-191792328	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs368434492	chr1:191792337-191792338	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs181206860	chr1:191792342-191792343	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs531910304	chr1:191792375-191792376	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs186904506	chr1:191792376-191792377	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs148380324	chr1:191792442-191792443	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs533831581	chr1:191792478-191792479	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs553909425	chr1:191792493-191792494	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs199978820	chr1:191792494-191792495	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs56129465	chr1:191792521-191792522	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs373131401	chr1:191792523-191792524	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs78926369	chr1:191792525-191792526	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs570436482	chr1:191792527-191792528	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs539458942	chr1:191792529-191792530	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs61593904	chr1:191792546-191792547	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs371583887	chr1:191792547-191792548	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs150871813	chr1:191792610-191792611	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs140132728	chr1:191792633-191792634	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs541996672	chr1:191792665-191792666	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs74931132	chr1:191792681-191792682	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs16833837	chr1:191792703-191792704	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs190334689	chr1:191792729-191792730	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs540988484	chr1:191792732-191792733	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs560227391	chr1:191792789-191792790	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs532355890	chr1:191792791-191792792	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs113190267	chr1:191792809-191792810	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs563192115	chr1:191792818-191792819	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs531953500	chr1:191792824-191792825	Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	20688739	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21611746	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	17393978	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Non-small cell lung cancer	19010865	CNVD
Mental retardation	17847001	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Trisomy 5 syndrome	21098271	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Lung adenocarcinoma	17086460	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	17086460	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD

Chromatin state (count:24 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:191791600-191791800	Enhancers	K562	blood
2	chr1:191791600-191792400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr1:191791600-191792600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr1:191791800-191793000	Flanking Active TSS	K562	blood
5	chr1:191791800-191793600	Enhancers	Primary hematopoietic stem cells	blood
6	chr1:191791800-191793600	Enhancers	Dnd41	blood
7	chr1:191792200-191793000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr1:191792200-191793600	Enhancers	Primary hematopoietic stem cells short term culture	blood
9	chr1:191792200-191793600	Enhancers	HUVEC	blood vessel
10	chr1:191792400-191792800	Enhancers	Fetal Brain Male	brain
11	chr1:191792400-191793200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr1:191792400-191793400	Enhancers	Fetal Lung	lung
13	chr1:191792600-191793000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr1:191792600-191793200	Enhancers	Fetal Heart	heart
15	chr1:191792800-191793200	Enhancers	Brain Hippocampus Middle	brain
16	chr1:191792800-191793200	Enhancers	Fetal Stomach	stomach
17	chr1:191792800-191793400	Enhancers	Duodenum Smooth Muscle	Duodenum
18	chr1:191792800-191793400	Active TSS	Fetal Brain Male	brain
19	chr1:191793000-191793200	Enhancers	K562	blood
20	chr1:191793000-191793400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr1:191793000-191793600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr1:191793200-191793400	Flanking Active TSS	K562	blood
23	chr1:191793200-191793600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr1:191798000-191798600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links